Browsing by Author "Kilinç, M"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item MORPHOLOGY AND ANATOMY OF THREE SUBSP OF CROCUS SPECIOSUS BIEB.Özdemir, C; Kilinç, MMoprhology and anatomy of Crocus speciosus Bieb. subsp. speciosus, C. speciosus Bieb. subsp. ilgazensis, C. speciosus subsp. xantholahnos were done. Two of them (subsp. ilgazensis and xantholahnos) are endemic to small areas of Turkey. The subsp. xantholaimos has flowers with tube stained yellow. The subsp. ilgazensis has a corm splitting into vertical fibres. These properties are characteristic for the two subspecies investigated. Cross-sections of root and aerial stem of three subspecies were examined and characterized. A key to the identification of the three taxa, based solely on anatomical features is provided here.Item The Future of Smart Campuses: Combining Digital Twin and Green MetricsTeke, I; Teke, O; Kilinç, MThe Smart Campus concept combines environmental sustainability and technological innovation and plays an important role in educational institutions. In this context the contribution of Digital Twins and Green metrics (GM) to smart campus is one of the important areas of research. In this study, a digital twin architecture is proposed, including energy and climate change, waste and water issues, which account for 48% in GM criteria. Digital simulation and communication protocols, predictive analysis and dynamic decision support can be synthesized between the physical world and the sensor-based framework. This synthesis reveals the potential to reduce environmental damage through effective waste management, efficient use of water resources, identification of efficiency gaps through real-time analysis of energy consumption, and reduction of carbon footprint through energy savings. This study aims that the combined approach presented with the proposed framework according to GM criteria will contribute to future educational environments by ensuring smart campus sustainability.Item What We Learned about COVID-19 So Far? Notes from UndergroundAkyil, FT; Karadogan, D; Gürkan, CG; Yüksel, A; Arikan, H; Eyüboglu, TS; Emiralioglu, N; Gürsoy, TR; Serifoglu, I; Toreyin, ZN; Marim, F; Kara, BY; Özakinci, H; Develi, E; Çakmakci, S; Kusbeci, TC; Karcioglu, O; Gulhan, PY; Erçelik, M; Er, B; Ataoglu, Ö; Polat, D; Kaya, I; Önyilmaz, TA; Aydin, A; Kizilirmak, D; Er, AB; Kilinç, M; Günaydin, FE; Gürz, S; Karaoglanoglu, S; Çelik, S; Esendagli, D; Toptay, H; Sertçelik, UÖ; Akgün, MThe novel coronavirus pandemic poses a major global threat to public health. Our knowledge concerning every aspect of COVID-19 is evolving rapidly, given the increasing data from all over the world. In this narrative review, the Turkish Thoracic Society Early Career Taskforce members aimed to provide a summary on recent literature regarding epidemiology, clinical findings, diagnosis, treatment, prevention, and control of COVID-19. Studies revealed that the genetic sequence of the novel coronavirus showed significant identity to SARS-CoV and MERS-CoV. Angiotensin-converting enzyme 2 receptor is an important target of the SARS-CoV-2 while entering an organism. Smokers were more likely to develop the disease and have a higher risk for ICU admission. The mean incubation period was 6.4 days, whereas asymptomatic transmission was reported up to 25 days after infection. Fever and cough were the most common symptoms, and cardiovascular diseases and hypertension were reported to be the most common comorbidities among patients. Clinical manifestations range from asymptomatic and mild disease to severe acute respiratory distress syndrome. Several patients showed typical symptoms and radiological changes with negative RT-PCR but positive IgG and IgM antibodies. Although radiological findings may vary, bilateral, peripherally distributed, ground-glass opacities were typical of COVID-19. Poor prognosis was associated with older age, higher Sequential Organ Failure Assessment score, and high D-dimer level. Chloroquine was found to be effective in reducing viral replication in vitro. Likewise, protease inhibitors, including lopinavir/ritonavir, favipiravir, and nucleoside analogue remdesivir were proposed to be the potential drug candidates in COVID-19 management. Despite these efforts, we still have much to learn regarding the transmission, treatment, and prevention of COVID-19.